Advanced search
Publication Cover
Biomarkers Volume 7, 2002 - Issue 1
Submit an article Journal homepage
78
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos

Martin Petrek Departments of Immunology
,
Cedric Hermans Departments of Industrial Toxicology and Occupational Medicine Unit, Catholic University of Louvain, Belgium
,
Vítězslav Kolek Departments of Respiratory Medicine and
,
Jarmila Fialová Departments of Occupational Medicine, Palacky University and University Hospital, Olomouc, Czech Republic
&
Alfred Bernard Departments of Industrial Toxicology and Occupational Medicine Unit, Catholic University of Louvain, Belgium
Pages 58-67 | Published online: 29 Sep 2008

  • BECKLAKE, M. R. 1991, Asbestos and other fiber-related diseases of the lung and pleura. Distribution and determinants in exposed populations. Chest, 100, 248-254.
  • BEGIN, R., CANTIN, A., BERTHIAUME, Y., BOILEAU, R., BISSON, G., LAMOUREUX, G., ROLA-PLESKCZYNSKI, M., DRAPEAU, G., MASSE, S. and BOCTOR, M. 1985, Clinical features to stage alveolitis in asbestos workers. American Journal of Industrial Medicine, 8, 521-536.
  • BERNARD, A. M. and LAUWERYS, R. R. 1983, Continuous-flow system for automation of latex immunoassay by particle counting. Clinical Chemistry, 29, 1007-1011.
  • BERNARD, A., LAUWERYS, R., NOEL, B., VANDELEENE, B. and LAMBERT, A. 1991, Determination by latex immunoassay of protein-1 in normal and pathological urine. Clinic a Chimica Acta, 201, 231-245.
  • BERNARD, A., MARCHANDISE, F. X, DEPELCHIN, S., LAUWERYS, R. and SIBILLE, Y. 1992, Clara cell protein in serum and bronchoalveolar lavage. European Respiratory Journal, 5, 1231-1238.
  • BERNARD, A. M., ROELS, H. A., BUCHET, J. P. and LAUWERYS, R. R. 1994a, Serum Clara cell protein: an indicator of bronchial cell dysfunction caused by tobacco smoking. Environmental Research, 66, 96-104.
  • BERNARD, A. M., GONZALEZ-LORENZO, J. M., SILES, E., TRUJILLANO, G. and LAUWERYS, R. 1994b, Early decrease of serum Clara cell protein in silica exposed workers. European Respiratory Journal, 7, 1932-1937.
  • BERNARD, A., HERMANS, C. and VAN HOUTE, G. 1997, Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occupational and Environmental Medicine, 54, 63-65.
  • BRODY, A. R., HILL, L.H. and WARHEIT, D. B. 1985, Induction of early alveolar injury by inhaled asbestos and silica. Federation Proceedings, 44, 2596-2601.
  • BROECKAERT, F., ARSALANE, K., HERMANS, C., BERGAMASCHI, E., BRUSTOLIN, A., MUTTI, A. and BERNARD, A. 1999, Lung epithelial damage at low concentrations of ambient ozone. Lancet, 353, 900-901.
  • BROSER, M., ZHANG, Y., ASION, C., HARKIN, T. and ROM, W. N. 1996, Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure. International Archives of Occupational and Environmental Health, 68, 109-114.
  • DOLL, R. 1955, Mortality from lung cancer in asbestos workers. British Journal of Industrial Medicate, 12, 81-86.
  • DOYLE, I. R., HERMANS, C., BERNARD, A., NICHOLAS, T. E. and BERSTEN, A. D. 1998, Clearance of Clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine, 158, 1528-1535.
  • GELLERT, A. R., MACEY, M. G. and UTHAYAKUMAR, S. 1985, Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers. American Review of Respiratory Diseases, 132, 824-828.
  • GREEN, F. H. Y., HARLEY, R., VALLYATHAN, V., ALTHOUSE, R., FICK, G., DEMENT, J., MITHA, R. and POOLEY, F., 1997, Exposure and mineralogical correlates of pulmonary fibrosis in chrysolite asbestos workers. Occupational and Environmental Medicine, 54, 549-559.
  • HERMANS, C. and BERNARD, A. 1996, Clara cell protein (CC16) characteristics and potential applications as biomarker of lung toxicity. Biomarkers, 1, 3-8.
  • HERMANS, C. and BERNARD, A. 1998, Pneumoproteinaemia: a new perspective in the assessment of lung disorders. European Respiratory Journal, 11, 801-803.
  • HERMANS, C. and BERNARD, A. 1999, Lung epithelium-specific proteins: characteristics and potential applications as markers. American Journal of Respiratory and Critical Care Medicine, 159, 646-678.
  • HERMANS, C., ALY, O., NYBERG, B. I., PETERSON, C. and BERNARD, A. 1998, Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays. Clinica Chimica Acta, 272, 101-110.
  • HURBANKOVA, M. 1999, Some new findings in the field of occupational dust exposition and lung diseases. I. Fibrous dust. Studio Pneumologica Phtiseologica, 59, 99-103 [in Slovak].
  • HURBANKOVA, M. and KAIGILOVA, A. 1993, The changes of some immunological parameters in subjects exposed to asbestos in dependence on age, duration of exposure, radiological findings and smoking habits. Zentralblatt für Hygiene und Umweltmedizin, 195, 55-65.
  • JAGIRDAR, J., LEE, T. C., REIBMAN, J., GOLD, L. L, ASION, C., BEGIN, R. and ROM, W. N. 1997, Immunohistochemical localization of transforming growth factor beta isoforms in asbestosrelated diseases. Environmental Health Perspectives, 105, Supplement 5, 1197-1203.
  • KOLEK, V., PETREK, M., FIAIJOVA, J., MYSLIVECEK, M., HERMAN, M. and DUSKOVA, M. 1996, The importance of determination of alveolar changes in workers with asbestos. Pracovni Lekarstvi, 48, 79-84 [in Czech].
  • LESUR, O., BERNARD, A., ARSALANE, K., LAUWERYS, R., BEGIN, R., CANTIN, A. and LANE, D. 1995, Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. American Journal of Respiratory and Critical Care Medicine, 152, 290-297.
  • LESUR, O., BERNARD, A. and BEGIN, R. O. 1996, Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers. Chest, 109, 467-474.
  • MAJURIN, M. L., VARPULA, M., KURKI, T. and PAKKALA, L. 1994, High-resolution CT of the lung in asbestos-exposed subjects. Comparison of low-dose and high-dose HRCT. Acta Radiologica, 35, 473-477.
  • MOSMAN, M. and GEE, J. B. 1989, Asbestos-related disease. New England Journal of Medicine, 32, 1721-1730.
  • MOSSMAN, B. T. and CHURG, A. 1998, Mechanisms in the pathogenesis of asbestosis and silicosis. American Journal of Respiratory and Critical Care Medicine, 157, 1666-1680.
  • MYSLIVECEK, M., HUSAK, V., KOLEK, V., BUDIKOVA, M. and KORANDA, P. 1992, Absolute quantification of 67-gallium citrate accumulation in the lung and its importance for the evaluation of pulmonary sarcoidosis activity. European Journal of Nuclear Medicine, 19, 1016-1022.
  • NAIR, P., RUPAWATZ, R. U., PRABHAKARAN, L. C., BIJUR, S. and KAMAT, S. R. 1991, Evaluating computed tomography and bronchoalveolar lavage in early diagnosis of pulmonary asbestosis. Sarcoidosis, 8, 115-119.
  • NAVRATIL, M. 1982, Asbestosis of the Lung and its Complications (Prague: Avicenum) [in Czech].
  • PENG, L. and WANG, X. 1993, Lymphocyte B and T cell subsets in peripheral blood from patients with asbestosis. British Journal of Industrial Medicine, 50, 183-184.
  • PETERSON, M. W., WALTER, M. E. and GROSS, T. J. 1993, Asbestos directly increases lung epithelial permeability. American Journal of Physiology, 265, L308-L317.
  • PETREK, M. 1991, Identification of lymphocyte subpopulations by indirect immunofluorescence - a micromethod. Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 129, 51-56.
  • QUINLAN, T. R., BERUBE, K. A., MARSH, J. P., JANSSEN, Y. M., TAISHI, P., LESLIE, K. O., HEMENWAY, D., O'SHAUGHNESSY, P. T., VACEK, P. and MOSSMAN, B. T. 1995, Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos. American Journal of Pathology, 147, 728-739.
  • RINDERKNECHT, J., SHAPIRO, L., KRAUTHAMMER M., TAPLIN, G., WASSERMAN, K., USZLER, J. M. and EROS, R. M. 1985, Accelerated clearance of small solutes from the lungs in interstitial lung disease. American Review of Respiratory Diseases, 121, 105-117.
  • ROM, W. N. and TRAVIS, W. D. 1992, Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos. Chest, 101, 779-786.
  • ROSENTHAL, G. J., SIMEONOVA, P. and CORSINI, E. 1999, Asbestos toxicity: an immunologie perspective. Reviews on Environmental Health, 14, 11-20.
  • SCHWARTZ, D. A., DAVIS, C. S., MERCHANT, J. A., BUNN, W. B., GALVIN, J. R., VAN FOSSEN, D. S., DAYHON, C. S. and HONNINGHAKE, G. W. 1994, Longitudinal changes in lung function among asbestos-exposed workers. American Journal of Respiratory and Critical Care Medicine, 150, 1243-1249.
  • SHIJUBO, N., ITOH, Y., YAMAGUCHI, T., SHIBUYA, Y., MORITA, Y., HIRASAWA, M., OKUTANI, R., KAWAI, T. and ABE, S. 1997, Serum and BAL Clara cell 10 kDA protein (CC-10) levels and CC-10-positive bronchiolar cells are decreased in smokers. European Respiratory Journal, 10, 1108-1114.
  • SINGH, G. and KATYAL, L. 1997, Clara cells and Clara cell 10 kDA protein (CC-10). American Journal of Respiratory Cell and Molecular Biology, 17, 141-143.
  • TESCHLER, H., KONIETZKO, N. and SCHOENFELD, B. 1993, Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. American Review of Respiratory Diseases, 147, 1211-1215.
  • TESCHLER, H., THOMPSON, A. B., DOLLENKAMP, R., KONIETZKO, N. and COSTABEL, U. 1996, Relevance of asbestos bodies. European Respiratory Journal, 9, 680-686.
  • TROSIC, I. and PISL, Z. 1995, Consequences of long-lasting asbestos-exposure peripheral blood parameters in shipyard workers with and without asbestosis. Experimental Toxicology and Pathology, 47, 212-216.
  • WAGNER, G. R. 1997, Asbestosis and silicosis. Lancet, 349, 1311-1315.
  • ZHANG, Y., LEE, T. C., GUILLEMIN, B., YU, M. C. and ROM, W. N. 1993, Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. Journal of Immunology, 150, 4188-4196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.